Replimune

hiring new hire appointment executive
Marketing

Bicara Therapeutics hires Replimune, Sanofi alum as CCO

As Bicara Therapeutics lines up for a potential accelerated cancer drug approval next year, the biotech has appointed a chief commercial officer.
Ben Adams May 12, 2026 7:24am
reducing people on team
Favicon Fierce Biotech

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am
dart board miss failure
Favicon Fierce Biotech

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm
FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm